Alnylam Pharmaceuticals Inc. (ALNY) Dipped -6.97% or -7.28 To Price $97.23 On Monday


Alnylam Pharmaceuticals Inc. (ALNY) dipped -6.97% or -7.28 to $97.23. It is close to 559584 shares traded, which is 91.65% compare to the average total volume 610587. The market cap of ALNY is $9.77 billion. The year to date change is -27.7%. The 52 week price range is from $70.76 to $153.99. Price of ALNY have changed -1.14% during last week. It have changed 6.11% over last month, 10.56% over last 3 months, -21.75% over last 6 months and 26.31% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ALNY is 102.36. It is 5.28% above current price. The 200-day Moving Averages for ALNY is 116.31. It is 19.62% above current price. The 52-week High is 153.99. It is 58.38% from the current price. The 52-week Low is 70.76. It is -27.22% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of ALNY is 8.21 on 2018-07-13. Short % to float is 5.09%. There are some statistics of ALNY. It is has market cap $9.77 billion. The share outstanding is 100.52 million. The average volume is 610587. The revenue is 70.95M. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ALNY is -40.59%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ALNY is -34.33%.


Tags:

Share this post